Concepts (255)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain | 29 | 2018 | 933 | 1.950 |
Why?
|
| Magnetic Resonance Imaging | 32 | 2018 | 1225 | 1.660 |
Why?
|
| Image Processing, Computer-Assisted | 11 | 2017 | 242 | 1.010 |
Why?
|
| Auditory Perception | 7 | 2009 | 80 | 0.860 |
Why?
|
| Brain Mapping | 16 | 2018 | 182 | 0.820 |
Why?
|
| Somatosensory Cortex | 2 | 2017 | 26 | 0.820 |
Why?
|
| Nerve Net | 9 | 2018 | 116 | 0.740 |
Why?
|
| Exercise | 5 | 2018 | 610 | 0.670 |
Why?
|
| Beta vulgaris | 2 | 2017 | 11 | 0.640 |
Why?
|
| Neuronal Plasticity | 2 | 2017 | 81 | 0.640 |
Why?
|
| Cerebral Infarction | 4 | 2008 | 24 | 0.640 |
Why?
|
| Visual Perception | 6 | 2009 | 113 | 0.600 |
Why?
|
| Visual Cortex | 6 | 2009 | 33 | 0.530 |
Why?
|
| Cerebrovascular Circulation | 9 | 2011 | 95 | 0.520 |
Why?
|
| Weight Loss | 4 | 2018 | 416 | 0.480 |
Why?
|
| Auditory Cortex | 4 | 2009 | 22 | 0.460 |
Why?
|
| Humans | 60 | 2019 | 29552 | 0.450 |
Why?
|
| Obesity | 6 | 2018 | 1081 | 0.430 |
Why?
|
| Cerebral Cortex | 5 | 2009 | 142 | 0.410 |
Why?
|
| Adult | 34 | 2018 | 8528 | 0.390 |
Why?
|
| Male | 38 | 2018 | 18012 | 0.370 |
Why?
|
| Aging | 6 | 2015 | 891 | 0.370 |
Why?
|
| Female | 37 | 2018 | 18379 | 0.360 |
Why?
|
| Music | 2 | 2007 | 9 | 0.340 |
Why?
|
| Career Mobility | 2 | 2019 | 14 | 0.340 |
Why?
|
| Acoustic Stimulation | 12 | 2018 | 125 | 0.330 |
Why?
|
| Aged | 24 | 2018 | 9590 | 0.330 |
Why?
|
| Prefrontal Cortex | 2 | 2013 | 69 | 0.330 |
Why?
|
| Attention | 3 | 2009 | 85 | 0.330 |
Why?
|
| Radiology | 2 | 2019 | 37 | 0.320 |
Why?
|
| Faculty, Medical | 2 | 2019 | 69 | 0.320 |
Why?
|
| Perception | 2 | 2012 | 92 | 0.310 |
Why?
|
| Neural Inhibition | 1 | 2008 | 27 | 0.310 |
Why?
|
| Cognition | 4 | 2016 | 529 | 0.310 |
Why?
|
| Middle Aged | 26 | 2018 | 10936 | 0.310 |
Why?
|
| Gyrus Cinguli | 2 | 2008 | 22 | 0.310 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2011 | 64 | 0.310 |
Why?
|
| Spin Labels | 5 | 2011 | 23 | 0.300 |
Why?
|
| Auditory Pathways | 2 | 2006 | 9 | 0.290 |
Why?
|
| Image Enhancement | 3 | 2009 | 70 | 0.280 |
Why?
|
| Dyslexia | 2 | 2005 | 8 | 0.280 |
Why?
|
| Tomography, X-Ray | 1 | 2006 | 5 | 0.280 |
Why?
|
| Walking | 2 | 2017 | 185 | 0.260 |
Why?
|
| Overweight | 2 | 2018 | 261 | 0.260 |
Why?
|
| Caffeine | 4 | 2009 | 31 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2018 | 113 | 0.250 |
Why?
|
| Software | 3 | 2015 | 110 | 0.250 |
Why?
|
| Nicotine | 2 | 2017 | 158 | 0.240 |
Why?
|
| Nitrates | 2 | 2017 | 25 | 0.240 |
Why?
|
| Pesticides | 2 | 2017 | 188 | 0.240 |
Why?
|
| Reference Books, Medical | 1 | 2004 | 2 | 0.240 |
Why?
|
| Software Validation | 1 | 2004 | 4 | 0.240 |
Why?
|
| Medical Informatics Applications | 1 | 2004 | 4 | 0.240 |
Why?
|
| Medical Illustration | 1 | 2004 | 7 | 0.240 |
Why?
|
| Tomography, Emission-Computed | 1 | 2004 | 25 | 0.240 |
Why?
|
| Echo-Planar Imaging | 2 | 2009 | 16 | 0.230 |
Why?
|
| Occupational Exposure | 2 | 2017 | 223 | 0.230 |
Why?
|
| Perfusion | 1 | 2004 | 64 | 0.230 |
Why?
|
| Frontal Lobe | 1 | 2004 | 45 | 0.230 |
Why?
|
| Photic Stimulation | 10 | 2009 | 156 | 0.230 |
Why?
|
| Data Interpretation, Statistical | 1 | 2003 | 105 | 0.220 |
Why?
|
| Internet | 1 | 2004 | 158 | 0.220 |
Why?
|
| Reaction Time | 5 | 2006 | 121 | 0.210 |
Why?
|
| Resistance Training | 3 | 2018 | 73 | 0.210 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2004 | 874 | 0.200 |
Why?
|
| Parietal Lobe | 2 | 2013 | 16 | 0.200 |
Why?
|
| Education, Medical, Graduate | 2 | 2019 | 116 | 0.190 |
Why?
|
| Neural Pathways | 5 | 2017 | 97 | 0.190 |
Why?
|
| Oxygen | 5 | 2017 | 139 | 0.180 |
Why?
|
| Reproducibility of Results | 5 | 2009 | 727 | 0.170 |
Why?
|
| Double-Blind Method | 3 | 2017 | 507 | 0.170 |
Why?
|
| Mentors | 1 | 2019 | 29 | 0.170 |
Why?
|
| Memory, Short-Term | 2 | 2016 | 60 | 0.160 |
Why?
|
| Body Composition | 2 | 2017 | 367 | 0.160 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 44 | 0.160 |
Why?
|
| Dietary Supplements | 2 | 2017 | 172 | 0.150 |
Why?
|
| Pain | 2 | 2011 | 285 | 0.150 |
Why?
|
| Military Personnel | 1 | 2018 | 86 | 0.150 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2009 | 130 | 0.150 |
Why?
|
| Quality of Life | 3 | 2017 | 833 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 2 | 2009 | 48 | 0.140 |
Why?
|
| Disability Evaluation | 1 | 2017 | 215 | 0.140 |
Why?
|
| Psychomotor Performance | 3 | 2005 | 97 | 0.140 |
Why?
|
| Cerebellum | 2 | 2013 | 29 | 0.140 |
Why?
|
| Central Nervous System Stimulants | 2 | 2009 | 74 | 0.130 |
Why?
|
| Nitrites | 2 | 2017 | 20 | 0.130 |
Why?
|
| Nonlinear Dynamics | 1 | 2014 | 52 | 0.120 |
Why?
|
| Gambling | 1 | 2014 | 6 | 0.120 |
Why?
|
| Emigrants and Immigrants | 1 | 2017 | 234 | 0.120 |
Why?
|
| Functional Laterality | 3 | 2011 | 59 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2016 | 248 | 0.110 |
Why?
|
| Brain Injuries | 2 | 2011 | 94 | 0.110 |
Why?
|
| Thalamus | 1 | 2013 | 39 | 0.110 |
Why?
|
| Analysis of Variance | 6 | 2011 | 455 | 0.110 |
Why?
|
| Hispanic Americans | 2 | 2017 | 903 | 0.110 |
Why?
|
| Choice Behavior | 1 | 2014 | 83 | 0.110 |
Why?
|
| Geriatric Assessment | 1 | 2015 | 363 | 0.110 |
Why?
|
| Motor Activity | 1 | 2015 | 315 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2013 | 119 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2016 | 3764 | 0.110 |
Why?
|
| Mobility Limitation | 1 | 2014 | 197 | 0.110 |
Why?
|
| Social Control, Informal | 1 | 2012 | 7 | 0.100 |
Why?
|
| Appetite | 1 | 2012 | 19 | 0.100 |
Why?
|
| Decision Making | 1 | 2014 | 182 | 0.100 |
Why?
|
| Food Preferences | 1 | 2012 | 36 | 0.100 |
Why?
|
| Heart Failure | 1 | 2017 | 576 | 0.100 |
Why?
|
| Diet | 2 | 2012 | 356 | 0.100 |
Why?
|
| Putamen | 1 | 2011 | 25 | 0.100 |
Why?
|
| Holistic Health | 1 | 2011 | 6 | 0.100 |
Why?
|
| Therapeutic Touch | 1 | 2011 | 10 | 0.100 |
Why?
|
| Young Adult | 6 | 2015 | 2431 | 0.100 |
Why?
|
| Comprehension | 1 | 2011 | 19 | 0.100 |
Why?
|
| Intracranial Arteriovenous Malformations | 1 | 2011 | 18 | 0.100 |
Why?
|
| Pruritus | 1 | 2011 | 58 | 0.090 |
Why?
|
| Cues | 3 | 2006 | 67 | 0.090 |
Why?
|
| Hypertension | 1 | 2017 | 918 | 0.090 |
Why?
|
| Neuropsychological Tests | 4 | 2015 | 381 | 0.090 |
Why?
|
| Diagnosis, Differential | 3 | 2008 | 493 | 0.090 |
Why?
|
| Perfusion Imaging | 1 | 2009 | 7 | 0.090 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2009 | 33 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2009 | 11 | 0.080 |
Why?
|
| Perceptual Disorders | 1 | 2009 | 7 | 0.080 |
Why?
|
| Information Storage and Retrieval | 1 | 2009 | 25 | 0.080 |
Why?
|
| Brain Diseases | 1 | 2009 | 40 | 0.080 |
Why?
|
| Models, Neurological | 2 | 2014 | 115 | 0.080 |
Why?
|
| Regression Analysis | 3 | 2017 | 275 | 0.080 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2008 | 9 | 0.080 |
Why?
|
| Models, Biological | 1 | 2010 | 375 | 0.080 |
Why?
|
| Cerebral Arteries | 1 | 2008 | 18 | 0.080 |
Why?
|
| Neurologic Examination | 2 | 2011 | 28 | 0.080 |
Why?
|
| Retrospective Studies | 5 | 2017 | 3144 | 0.080 |
Why?
|
| Hemiplegia | 1 | 2007 | 12 | 0.080 |
Why?
|
| Arm | 1 | 2007 | 31 | 0.070 |
Why?
|
| Radiosurgery | 1 | 2011 | 325 | 0.070 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2007 | 31 | 0.070 |
Why?
|
| Hand | 1 | 2007 | 63 | 0.070 |
Why?
|
| Contrast Media | 2 | 2009 | 124 | 0.070 |
Why?
|
| Coffee | 2 | 2003 | 10 | 0.070 |
Why?
|
| Rest | 2 | 2017 | 50 | 0.070 |
Why?
|
| Cotinine | 2 | 2017 | 45 | 0.070 |
Why?
|
| Time Perception | 1 | 2006 | 6 | 0.070 |
Why?
|
| Judgment | 1 | 2006 | 11 | 0.070 |
Why?
|
| Pitch Discrimination | 1 | 2005 | 1 | 0.070 |
Why?
|
| Diffusion | 2 | 2002 | 13 | 0.070 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 533 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2006 | 46 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1058 | 0.070 |
Why?
|
| Discrimination Learning | 1 | 2005 | 20 | 0.070 |
Why?
|
| Single-Blind Method | 3 | 2017 | 174 | 0.060 |
Why?
|
| Internship and Residency | 2 | 2019 | 283 | 0.060 |
Why?
|
| Time Factors | 3 | 2006 | 2014 | 0.060 |
Why?
|
| Muscle Strength | 2 | 2017 | 145 | 0.060 |
Why?
|
| Adolescent | 5 | 2011 | 3284 | 0.060 |
Why?
|
| Probability | 2 | 2017 | 151 | 0.060 |
Why?
|
| Blood Volume | 1 | 2004 | 6 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2003 | 16 | 0.060 |
Why?
|
| Sound Localization | 1 | 2003 | 6 | 0.060 |
Why?
|
| Myopia | 1 | 2003 | 5 | 0.060 |
Why?
|
| Arousal | 1 | 2003 | 19 | 0.060 |
Why?
|
| Terminology as Topic | 1 | 2004 | 63 | 0.060 |
Why?
|
| Stroke | 1 | 2009 | 552 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2005 | 861 | 0.060 |
Why?
|
| Brain Edema | 1 | 2003 | 16 | 0.060 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2003 | 24 | 0.050 |
Why?
|
| Age Factors | 3 | 2014 | 1120 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2014 | 129 | 0.050 |
Why?
|
| Psychophysiology | 1 | 2002 | 2 | 0.050 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 139 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2002 | 13 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2002 | 11 | 0.050 |
Why?
|
| Hearing | 1 | 2002 | 11 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2002 | 13 | 0.050 |
Why?
|
| Language | 1 | 2002 | 44 | 0.050 |
Why?
|
| Research Design | 1 | 2004 | 289 | 0.050 |
Why?
|
| Acute Disease | 1 | 2002 | 239 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 588 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2011 | 59 | 0.040 |
Why?
|
| Pain Threshold | 2 | 2011 | 95 | 0.040 |
Why?
|
| Organizational Objectives | 1 | 2019 | 23 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2011 | 365 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2124 | 0.040 |
Why?
|
| Statistics as Topic | 2 | 2009 | 107 | 0.040 |
Why?
|
| Regional Blood Flow | 2 | 2010 | 82 | 0.040 |
Why?
|
| Acetylcholinesterase | 1 | 2017 | 17 | 0.040 |
Why?
|
| Child | 3 | 2011 | 2233 | 0.040 |
Why?
|
| Diet, Reducing | 1 | 2018 | 90 | 0.040 |
Why?
|
| Sensory Thresholds | 2 | 2009 | 26 | 0.040 |
Why?
|
| Butyrylcholinesterase | 1 | 2017 | 15 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2016 | 3128 | 0.040 |
Why?
|
| Physical Endurance | 1 | 2017 | 31 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2015 | 1701 | 0.040 |
Why?
|
| ROC Curve | 1 | 2016 | 149 | 0.030 |
Why?
|
| Cholinesterases | 1 | 2016 | 10 | 0.030 |
Why?
|
| Models, Statistical | 1 | 2017 | 164 | 0.030 |
Why?
|
| Behavior Therapy | 1 | 2016 | 92 | 0.030 |
Why?
|
| Exercise Therapy | 1 | 2018 | 237 | 0.030 |
Why?
|
| Psychometrics | 1 | 2015 | 129 | 0.030 |
Why?
|
| Information Theory | 1 | 2014 | 3 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2017 | 282 | 0.030 |
Why?
|
| Agriculture | 1 | 2016 | 174 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 369 | 0.030 |
Why?
|
| Behavior | 1 | 2013 | 29 | 0.030 |
Why?
|
| Personal Satisfaction | 1 | 2013 | 26 | 0.030 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 51 | 0.030 |
Why?
|
| Reward | 1 | 2014 | 63 | 0.030 |
Why?
|
| Infant | 2 | 2009 | 976 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 2016 | 280 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2017 | 813 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2009 | 1172 | 0.030 |
Why?
|
| Reference Values | 2 | 2003 | 225 | 0.030 |
Why?
|
| Drive | 1 | 2012 | 2 | 0.030 |
Why?
|
| Postprandial Period | 1 | 2012 | 10 | 0.030 |
Why?
|
| Taste | 1 | 2012 | 15 | 0.030 |
Why?
|
| Bone Density | 1 | 2013 | 183 | 0.030 |
Why?
|
| Water | 1 | 2012 | 53 | 0.030 |
Why?
|
| Behavior, Addictive | 1 | 2012 | 31 | 0.030 |
Why?
|
| North Carolina | 1 | 2016 | 1430 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2011 | 19 | 0.030 |
Why?
|
| Psychoacoustics | 1 | 2011 | 2 | 0.020 |
Why?
|
| Self Efficacy | 1 | 2012 | 72 | 0.020 |
Why?
|
| Energy Intake | 1 | 2012 | 120 | 0.020 |
Why?
|
| Afferent Pathways | 1 | 2011 | 23 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 53 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 214 | 0.020 |
Why?
|
| Mental Processes | 1 | 2010 | 17 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2012 | 159 | 0.020 |
Why?
|
| Hyperalgesia | 1 | 2011 | 88 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2011 | 333 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 3600 | 0.020 |
Why?
|
| Saliva | 1 | 2009 | 36 | 0.020 |
Why?
|
| Animals | 2 | 2011 | 7339 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2009 | 11 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2009 | 172 | 0.020 |
Why?
|
| Arteries | 1 | 2009 | 61 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2009 | 74 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 643 | 0.020 |
Why?
|
| Motor Skills | 1 | 2007 | 12 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 2009 | 136 | 0.020 |
Why?
|
| Movement | 1 | 2007 | 41 | 0.020 |
Why?
|
| Fingers | 1 | 2007 | 57 | 0.020 |
Why?
|
| Algorithms | 1 | 2010 | 468 | 0.020 |
Why?
|
| Organ Size | 1 | 2007 | 196 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2008 | 177 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2007 | 190 | 0.020 |
Why?
|
| Visual Pathways | 1 | 2006 | 30 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2005 | 51 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2008 | 376 | 0.020 |
Why?
|
| Cerebral Ventriculography | 1 | 2003 | 3 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2003 | 5 | 0.010 |
Why?
|
| Intracranial Pressure | 1 | 2003 | 19 | 0.010 |
Why?
|
| Fixation, Ocular | 1 | 2002 | 5 | 0.010 |
Why?
|
| Linear Models | 1 | 2003 | 427 | 0.010 |
Why?
|
| Acetazolamide | 1 | 2002 | 1 | 0.010 |
Why?
|
| Anisotropy | 1 | 2002 | 10 | 0.010 |
Why?
|
| Cadaver | 1 | 2002 | 145 | 0.010 |
Why?
|